跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
爱必妥 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Cetuximab Solution for Infusion
Approved
生物制品
Cetuximab Solution for Infusion
Merck Europe BV
🇨🇳 National Medical Products Administration
Approval Date
Oct 10, 2022
Approval ID
ffac406bfaa827c8
Company
Merck Europe BV
Type
生物制品
Approval Details
Approval Id
ffac406bfaa827c8
Approval Number
国药准字SJ20171039
Generic Name
西妥昔单抗注射液
Generic Name En
Cetuximab Solution for Infusion
Trade Name
爱必妥
Drug Type
生物制品
Dosage Form
注射剂
Strength
100mg/20ml/瓶
Reg Date
2022-10-10
Expired Date
2027-10-09
Company Name
Merck Europe BV
Production Company Name
Merck Healthcare KGaA
Company Detail Path
/organization/merck-europe-bv
Production Company Detail Path
/organization/merck-healthcare-kgaa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 10, 2022
Approval ID
ffac406bfaa827c8
Type
生物制品
Back to NMPA Approvals